The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Our Reviewers: (Editorial)
Open accessAbstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Now the most widely read journal in psychiatry and one of the most cited in the field, JCP is blessed with a growing number of manuscript submissions. What had previously been stacks of paper manuscripts that strained my back as well as eyes, now has become a stream of electrons, as JCP's submissin and review process went on-line at the beginning of 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
Willett, W. C., Dietz, W. H., & Colditz, G. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410607 · Cited by 1,143
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Assmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90550-i · Cited by 872
Body Mass Index and the Prevalence of Hypertension and Dyslipidemia
Brown, C. D., Higgins, M., Donato, K. A., Rohde, F. C., Garrison, R., Obarzanek, E., Ernst, N. D., & Horan, M. (2000) · Obesity Research · doi:10.1038/oby.2000.79 · Cited by 851
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Reaven, G. M., Chen, Y. D., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 690
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 635
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 545
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Newcomer, J. W., Haupt, D. W., Fucetola, R., Melson, A. K., Schweiger, J. A., Cooper, B. P., & Selke, G. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.337 · Cited by 520
HEBERT, P. R., GAZIANO, J. M., CHAN, K. S., & HENNEKENS, C. H. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199806000-00060 · Cited by 506
Lindenmayer, J.-P., Czobor, P., Volavka, J., Citrome, L., Sheitman, B., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.290 · Cited by 465
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L., Kreyenbuhl, J., Revicki, D., & Buchanan, R. (2002) · BMJ · doi:10.1136/bmj.325.7358.243 · Cited by 421
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
The Distribution of Body Mass Index Among Individuals With and Without Schizophrenia
Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Cappelleri, J. C., Chandler, L. P., Weiden, P. J., & Cheskin, L. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0402 · Cited by 390
Obesity, Metabolic Syndrome, and Coronary Atherosclerosis
Grundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000020650.86137.84 · Cited by 380
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
The Association of Medical Comorbidity in Schizophrenia with Poor Physical and Mental Health
DIXON, L., POSTRADO, L., DELAHANTY, J., FISCHER, P. J., & LEHMAN, A. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199908000-00006 · Cited by 360
WHO reassesses appropriate body-mass index for Asian populations
Choo, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09512-0 · Cited by 336
Olanzapine‐Associated Diabetes Mellitus
Koller, E. A., & Doraiswamy, P. M. (2002) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.11.841.33629 · Cited by 303
Hyperglycemic Crises in Urban Blacks
Umpierrez, G. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.6.669 · Cited by 295
Lamarche, B., Lemieux, I., & Després, J. (1999) · PubMed · Cited by 281
Meyer, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0509 · Cited by 267
Fibrinogen and coronary heart disease--what does it mean?
Assmann, G., Schulte, H., Funke, H., & von Eckardstein, A. (1998) · PubMed · Cited by 256
Koller, E., Schneider, B., Bennett, K., & Dubitsky, G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01000-2 · Cited by 250
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L. S., Kreyenbuhl, J., Revicki, D., & Buchanan, R. W. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1021 · Cited by 234
Hyperglycemia and antipsychotic medications.
Haupt, D. W., & Newcomer, J. W. (2001) · PubMed · Cited by 233
Casey, D. E., Daniel, D. G., Wassef, A. A., Tracy, K. A., Wozniak, P., & Sommerville, K. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300023 · Cited by 232
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate
Fontaine, K. R., Heo, M., Harrigan, E. P., Shear, C. L., Lakshminarayanan, M., Casey, D. E., & Allison, D. B. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00234-7 · Cited by 230
Lipton, R. B., Uao, Y., Cao, G., Cooper, R. S., & McGee, D. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116786 · Cited by 196
Rifai, N., & Ridker, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.1.28 · Cited by 193
Montanez, A., Ruskin, J. N., Hebert, P. R., Lamas, G. A., & Hennekens, C. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.943 · Cited by 190
TERRY, R. B., WOOD, P. D., HASKELL, W. L., STEFANICK, M. L., & KRAUSS, R. M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-191 · Cited by 179
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States
Buse, J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00588-7 · Cited by 176
Novel Antipsychotics and Severe Hyperlipidemia
Meyer, J. M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00003 · Cited by 168
Risperidone‐Associated Diabetes Mellitus: A Pharmacovigilance Study
Koller, E. A., Cross, J. T., Doraiswamy, P. M., & Schneider, B. S. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.735.32178 · Cited by 160
New Profiles of Diabetic Ketoacidosis
Balasubramanyam, A., Zern, J. W., Hyman, D. J., & Pavlik, V. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.19.2317 · Cited by 157
Dosing the antipsychotic medication olanzapine.
Nemeroff, C. B. (1997) · PubMed · Cited by 153
Dietary Antioxidants and Cardiovascular Disease
Gaziano, J. M., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb17104.x · Cited by 151
Characteristics of Diabetic Ketoacidosis in Older versus Younger Adults
Malone, M. L., Gennis, V. M., & Goodwin, J. S. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01797.x · Cited by 150
Differential effects of BMI on diabetes risk among black and white Americans.
Resnick, H. E., Valsania, P., Halter, J. B., & Lin, X. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1828 · Cited by 147
Banerji, M. A., Lebowitz, J., Chaiken, R. L., Gordon, D., Kral, J. G., & Lebovitz, H. E. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e425 · Cited by 142
Epidemiology of hypertriglyceridemia and cardiovascular disease
Austin, M. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00209-x · Cited by 138
The Risk of Diabetes During Olanzapine Use Compared With Risperidone Use
Jaime, J., Ward, A., Levinton, C. M., & Robinson, K. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1208 · Cited by 131
Albrink, M. J., Krauss, R. M., Lindgren, F. T., von der Groeben, J., Pan, S., & Wood, P. D. (1980) · Lipids · doi:10.1007/bf02534017 · Cited by 128
Schizophrenia and smoking: Evidence for a common neurobiological basis?
Stassen, H. H., Bridler, R., H�gele, S., Hergersberg, M., Mehmann, B., Schinzel, A., Weisbrod, M., & Scharfetter, C. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000403)96:2<173::aid-ajmg10>3.0.co;2-u · Cited by 86
Antipsychotic-associated weight gain and clinical outcome parameters.
Blin, O., & Micallef, J. (2001) · PubMed · Cited by 73
Fuller, M. A., Shermock, K. M., Secic, M., & Grogg, A. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.8.1037.32876 · Cited by 72
THE BLOOD SUGAR CURVE IN MENTAL DISEASE: II. THE SCHIZOPHRENIC (DEMENTIA PRAECOX) GROUPS
KASANIN, J. (1926) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1926.02200280022002 · Cited by 62
Rhabdomyolysis, Pancreatitis, and Hyperglycemia With Ziprasidone
Yang, S. H., & McNeely, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1435 · Cited by 60
Type 2 diabetes mellitus: the grand overview
Ratner, R. E. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(1998120)15:4+<s4::aid-dia735>3.0.co;2-1 · Cited by 44
Feldman, P. D., Hay, L. K., Deberdt, W. G., Kennedy, J. S., Hutchins, D. S., Hay, D. P., Hardy, T. A., Hoffmann, V. P., Hornbuckle, K., & Breier, A. F. (2004) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70042-0 · Cited by 42
Banerji, M. A. (2002) · PubMed · Cited by 40
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
“This excess mortality is not only caused by increased suicide; people with SMI have an increased risk of mortality associated with physical illness, with the commonest cause of death being cardiovascular disease (CVD) [15,16,17,25,26,65,82,103,104, 106,107].”
BackgroundAtypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Metadata
- Authors
- Gelenberg, A. J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-01-15
- Volume
- 65
- Issue
- 1
- Pages
- 4-7
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W150965689
- Cited by
- 356
- References
- 75
- FWCI
- 246.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.